| scholarly article | Q13442814 |
| P50 | author | Euridice Carmona | Q67521456 |
| P2093 | author name string | Barbara C Vanderhyden | |
| Manijeh Daneshmand | |||
| Kenneth Garson | |||
| Olga Collins | |||
| Lisa F Gamwell | |||
| Ensaf M Al-Hujaily | |||
| Elizabeth A Macdonald | |||
| Lauren E Carter | |||
| Curtis W McCloskey | |||
| Reuben L Goldberg | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer | Q24323885 | ||
| Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma | Q26998068 | ||
| Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
| A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. | Q29417084 | ||
| Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells | Q39564832 | ||
| Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer | Q39668407 | ||
| Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells | Q39748143 | ||
| Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer. | Q39898694 | ||
| Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer | Q40045294 | ||
| Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer | Q40164561 | ||
| Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets. | Q40358652 | ||
| Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer | Q40488126 | ||
| Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. | Q40506716 | ||
| Development of a syngeneic mouse model for events related to ovarian cancer | Q40888613 | ||
| Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity | Q41033264 | ||
| Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. | Q41171492 | ||
| Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and RAS pathway aberrations | Q47266001 | ||
| The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae | Q47907453 | ||
| The mouse ovarian surface epithelium contains a population of LY6A (SCA-1) expressing progenitor cells that are regulated by ovulation-associated factors | Q48641462 | ||
| Changes in gene expression during progression of ovarian carcinoma | Q49222374 | ||
| Microarray proteomic analysis discriminates tumorigenic mouse ovarian surface epithelial cells of divergent aggressive potential | Q51649163 | ||
| A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin. | Q53323063 | ||
| Serous carcinogenesis in the fallopian tube: a descriptive classification. | Q53325750 | ||
| Silencing of the UCHL1 gene in human colorectal and ovarian cancers. | Q53346854 | ||
| Serum Autotaxin is not a Useful Biomarker for Ovarian Cancer | Q59939722 | ||
| CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer | Q61608137 | ||
| Species- and cell type-specific requirements for cellular transformation | Q80482709 | ||
| Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types | Q83855414 | ||
| Epiregulin as a marker for the initial steps of ovarian cancer development | Q84571422 | ||
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube. | Q33264156 | ||
| Cancer stem cells: a stride towards cancer cure? | Q34086837 | ||
| Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours | Q34097804 | ||
| Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer | Q34126314 | ||
| LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication. | Q34253325 | ||
| Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche | Q34331396 | ||
| Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. | Q34519901 | ||
| Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model | Q34769954 | ||
| Distinct requirements for Ras oncogenesis in human versus mouse cells | Q34787097 | ||
| Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer | Q34871343 | ||
| A mouse model for the molecular characterization of brca1-associated ovarian carcinoma | Q35646878 | ||
| Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin | Q35914413 | ||
| Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells | Q36164111 | ||
| Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival. | Q36201267 | ||
| Cyclin D1 predicts the prognosis of advanced serous ovarian cancer | Q36230481 | ||
| Methylation of tumor suppressor genes in ovarian cancer | Q36386613 | ||
| Induction of ovarian cancer by defined multiple genetic changes in a mouse model system | Q36496578 | ||
| Technical challenges and limitations of current mouse models of ovarian cancer | Q36510070 | ||
| Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer | Q36663567 | ||
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer | Q36956156 | ||
| Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells | Q37065361 | ||
| Histologic subtypes of ovarian carcinoma: an overview. | Q37101055 | ||
| Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms | Q37119791 | ||
| Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway | Q37203864 | ||
| Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model | Q37365555 | ||
| Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. | Q37381736 | ||
| Epithelial ovarian cancer experimental models. | Q37708938 | ||
| Ovarian cancer stem cells: working towards the root of stemness | Q38058671 | ||
| Cancer stem cells niche: a target for novel cancer therapeutics | Q38065528 | ||
| Revisiting ovarian cancer preclinical models: implications for a better management of the disease | Q38083980 | ||
| Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis? | Q38096167 | ||
| Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis | Q38287695 | ||
| Thrombomodulin mediates the progression of epithelial ovarian cancer cells | Q39114905 | ||
| Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo | Q39136622 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| M0505 | Q54903413 | ||
| STOSE | Q54970603 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| cell line | Q21014462 | ||
| P304 | page(s) | 53 | |
| P577 | publication date | 2014-03-18 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population | |
| P478 | volume | 4 |
| Q47160447 | 17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression |
| Q95933360 | Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids |
| Q37686049 | BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions |
| Q91004442 | BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway |
| Q90193380 | Characteristics of in Vivo Model Systems for Ovarian Cancer Studies |
| Q57699553 | Discrimination of normal and malignant mouse ovarian surface epithelial cells in vitro using Raman microspectroscopy |
| Q36097633 | Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins |
| Q26783909 | Emerging and Evolving Ovarian Cancer Animal Models |
| Q48600293 | Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. |
| Q89423005 | GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer |
| Q36413849 | Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression |
| Q30355682 | IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice. |
| Q37362760 | Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium |
| Q61810852 | Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model |
| Q96431876 | Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium |
| Q64911672 | Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics. |
| Q47160060 | PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state |
| Q61443800 | Prognostic values of GMPS, PR, CD40, and p21 in ovarian cancer |
| Q89454393 | Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model |
| Q91810300 | Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton |
| Q35859678 | Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors |
| Q58795166 | UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer |
| Q91297679 | WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer |
| Q50560992 | β-catenin downregulates Dicer to promote ovarian cancer metastasis. |
Search more.